Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane

References

• Ferri N, Corsini A, Bellosta S. Pharmacology of the New P2Y12 Receptor inhibitors: Insights on pharmacokinetic and pharmacodynamic properties. Drugs 2013;73(15):1681–1709.
   PubMed Web of Science ®Google Scholar
• Floyd CN, Passacquale G, Ferro A. Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications. Clin Pharmacokinet 2012;51(7):429–442.
   PubMed Web of Science ®Google Scholar
• James S, Akerblom A, Cannon CP, Emanuelsson H, Husted S, Katus H, Skene A, Steg PG, Storey RF, Harrington R, et al. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J 2009;157(4):599–605.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New England J Med 2005;352(12):1179–1189.
   PubMed Web of Science ®Google Scholar
• Wallentin L. P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 2009;30(16):1964–1977.
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann F-J, Ardissino D, De Servi S, Murphy SA, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England J Med 2007;357(20):2001–2015.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England J Med 2009;361(11):1045–1057.
   PubMed Web of Science ®Google Scholar
• Wijeyeratne YD, Heptinstall S. Anti-platelet therapy: ADP receptor antagonists. Br J Clin Pharmacol 2011;72(4):647–657.
   PubMed Web of Science ®Google Scholar
• Bilbao PS, Katz S, Boland R. Interaction of purinergic receptors with GPCRs, ion channels, tyrosine kinase and steroid hormone receptors orchestrates cell function. Purinergic Signal 2012;8(1):91–103.
   PubMed Web of Science ®Google Scholar
• Quinton TM, Kim S, Jin J, Kunapuli SP. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. JTH 2005;3(5):1036–1041.
   Google Scholar
• Quinton TM, Murugappan S, Kim S, Jin J, Kunapuli SP. Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets. JTH 2004;2(6):978–984.
   Google Scholar
• Savi P, Zachayus J-L, Delesque-Touchard N, Labouret C, Hervé C, Uzabiaga M-F, Pereillo J-M, Culouscou J-M, Bono F, Ferrara P, et al. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci USA 2006;103(29):11069–11074.
   PubMed Web of Science ®Google Scholar
• Norambuena A, Poblete MI, Donoso MV, Espinoza CS, González A, Huidobro-Toro JP. P2Y1 receptor activation elicits its partition out of membrane rafts and its rapid internalization from human blood vessels: Implications for receptor signaling. Mol Pharmacol 2008;74(6):1666–1677.
   PubMed Web of Science ®Google Scholar
• Rabani V, Davani S, Gambert-Nicot S, Meneveau N, Montange D. Comparative lipidomics and proteomics analysis of platelet lipid rafts using different detergents. Platelets 2016;27(7):634–641.
   Web of Science ®Google Scholar
• Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226(1):497–509.
   PubMed Web of Science ®Google Scholar
• Edwards SH, Kimberly MM, Pyatt SD, Stribling SL, Dobbin KD, Myers GL. Proposed serum cholesterol reference measurement procedure by gas chromatography-isotope dilution mass spectrometry. Clin Chem 2011;57(4):614–622.
   PubMed Web of Science ®Google Scholar
• Rajendran L, Masilamani M, Solomon S, Tikkanen R, Stuermer CAO, Plattner H, Illges H. Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc Natl Acad Sci U S A 2003;100(14):8241–8246.
   PubMed Web of Science ®Google Scholar
• Solomon S, Masilamani M, Rajendran L, Bastmeyer M, Stuermer CAO, Illges H. The lipid raft microdomain-associated protein reggie-1/flotillin-2 is expressed in human B cells and localized at the plasma membrane and centrosome in PBMCs. Immunobiology 2002;205(1):108–119.
   PubMed Web of Science ®Google Scholar
• Langhorst MF, Reuter A, Jaeger FA, Wippich FM, Luxenhofer G, Plattner H, Stuermer CAO. Trafficking of the microdomain scaffolding protein reggie-1/flotillin-2. Eur J Cell Biol 2008;87(4):211–226.
   PubMed Web of Science ®Google Scholar
• Heijnen HFG, Van Lier M, Waaijenborg S, Ohno-Iwashita Y, Waheed AA, Inomata M, Gorter G, Möbius W, Akkerman JWN, Slot JW. Concentration of rafts in platelet filopodia correlates with recruitment of c-Src and CD63 to these domains. JTH 2003;1(6):1161–1173.
   Google Scholar
• Bassé F, Gaffet P, Bienvenüe A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: Are vesicles shed by filopod fragmentation? Biochim Biophys Acta 1994;1190(2):217–224.
   PubMed Web of Science ®Google Scholar
• Hughes M, Hayward CP, Warkentin TE, Horsewood P, Chorneyko KA, Kelton JG. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000;96(1):188–194.
   PubMed Web of Science ®Google Scholar
• Yano Y, Kambayashi J, Shiba E, Sakon M, Oiki E, Fukuda K, Kawasaki T, Mori T. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J 1994; 299(Pt 15):303–308.
   PubMed Web of Science ®Google Scholar
• Del Conde I, Shrimpton CN, Thiagarajan P, López JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005;106(5):1604–1611.
   PubMed Web of Science ®Google Scholar
• Biro E, Akkerman JWN, Hoek FJ, Gorter G, Pronk LM, Sturk A, Nieuwland R. The phospholipid composition and cholesterol content of platelet-derived microparticles: A comparison with platelet membrane fractions. J Thromb Haemostasis 2005;3(12):2754–2763.
   PubMed Web of Science ®Google Scholar
• Paoletta S, Sabbadin D, Von Kügelgen I, Hinz S, Katritch V, Hoffmann K, Abdelrahman A, Straßburger J, Baqi Y, Zhao Q, et al. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. J Comput Aided Mol Des 2015;29(8):737–756.
   PubMed Web of Science ®Google Scholar
• Serebruany VL. Viewpoint: Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel. Thromb Haemost 2012;108(6):1024–1027.
   PubMed Web of Science ®Google Scholar
• Gremmel T, Yanachkov IB, Yanachkova MI, Wright GE, Wider J, Undyala VVR, Michelson AD, Frelinger AL, Przyklenk K. synergistic inhibition of both P2Y1 and P2Y12 adenosine diphosphate receptors as novel approach to rapidly attenuate platelet-mediated thrombosissignificance. Arterioscler Thromb Vasc Biol 2016;36(3):501–509.
   PubMed Web of Science ®Google Scholar
• Hardy AR, Jones ML, Mundell SJ, Poole AW. Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood 2004;104(6):1745–1752.
   PubMed Web of Science ®Google Scholar
• Van Giezen JJJ, Nilsson L, Berntsson P, B-M W, Giordanetto F, Tomlinson W, Pj G. Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation. JTH 2009;7(9):1556–1565.
   Google Scholar
• Ibrahim S, McCartney A, Markosyan N, Smyth EM. Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts. Arterioscler Thromb Vasc Biol 2013;33(1):60–66.
   PubMed Web of Science ®Google Scholar